It is a healthcare private limited company based in Pune, Maharashtra, India, established in 2019.
2019 | Pune, Maharashtra, India | ActiveKappris Drug Private Limited, a active private limited company, was established on 02 May 2019 in Pune, Maharashtra, India. Engaging in medical equipment retail & distribution within the manufacturing sector, it holds CIN: U51397PN2019PTC183887. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Smith Suresh Chavan (Director), Gorakh Tanaji Ghadge (Director), Sachin Mahadeo Mali (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Flat No E-304, Water Fronts No 62/9/1, Ambegaon Kh., Pune, Maharashtra, 411046.
U51397PN2019PTC183887
183887
02 May 2019
₹0.10 M
₹0.10 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Kappris Drug Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Smith Suresh Chavan | Director | 02 May 2019 | Current |
| Gorakh Tanaji Ghadge | Director | 02 May 2019 | Current |
| Sachin Mahadeo Mali | Director | 02 May 2019 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Kappris Drug Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 477.88% increase. The company also saw a substantial improvement in profitability, with a 48.79% increase in profit. The company's net worth moved up by a moderate rise of 7.99%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Kappris Drug had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Kappris Drug, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Kappris Drug, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kappris Drug's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Kappris Drug Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Kappris Drug Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune. was documented.
The activity Smith Suresh Chavan was appointed as a Director was appointed as a Director on 02 May 2019 & has been associated with this company since 6 years 7 months . was completed.
Progress on Gorakh Tanaji Ghadge was appointed as a Director was appointed as a Director on 02 May 2019 & has been associated with this company since 6 years 7 months . was documented.
Sachin Mahadeo Mali was appointed as a Director was appointed as a Director on 02 May 2019 & has been associated with this company since 6 years 7 months . was recorded as a recent event.
The activity Kappris Drug Private Limited was registered on 02 May 2019 with Roc Pune & aged 6 years 7 months as per MCA records. was completed.
The CIN of Kappris Drug Private Limited is U51397PN2019PTC183887.
Kappris Drug Private Limited is headquartered at Flat No E-304, Water Fronts No 62/9/1, Ambegaon Kh., Pune, Maharashtra, 411046.
Kappris Drug Private Limited was incorporated on 02 May 2019.
The current directors of Kappris Drug Private Limited are
The primary industry of Kappris Drug Private Limited is Manufacturing.
Kappris Drug Private Limited is unlisted.
The authorized capital of Kappris Drug Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX